Neuronal nicotinic acetylcholine receptors (nAChRs) are involved in cognition, and may play a role in Alzheimer's disease (AD). Known inhibitors of acetylcholinesterase (AChE) are used to treat AD, and are known cognitive enhancers, however their mechanism of action relating to AD is not fully understood. We tested several AChE inhibitors, including huperzine A, tacrine, and BW284c51, on nAChRs in rat hippocampal CA1 interneurons in slices using patch-clamp techniques. These interneurons express both α7 and non-α7 subunit-containing nAChRs, and were activated with pressure applications of ACh, choline, or carbachol. These AChE inhibitors had no significant effect on either the amplitude or kinetics of α7 nAChRs activated by ACh, but slowed the rate of recovery from desensitization through an indirect mechanism; responses activated with either choline or carbachol were unaffected. For non-α7 receptors, these inhibitors significantly increased the amplitude and decay phase for responses induced by ACh (but not carbachol), also through an indirect mechanism.
the cell body; in this way, two agonists could be rapidly applied to the same cell. Brief (50-200 msec) duration pulses at 10-20 psi were typically used to activate α7-containing nAChRs, whereas longer (5 sec) pulses (< 10 psi) were typically used to activate non-α7 receptors. Drugs studied were diluted at final concentrations in ACSF and were delivered to the cell through a gravity-fed multichannel perfusion system ending with a nonmetallic syringe needle (250 µm ID, WPI) placed just above the slice surface to ensure the homogenous coverage of the area surrounding the cell being studied.
Data analysis.
To study the rate of recovery from desensitization of α7-containing receptors, the time (10 sec) between two consecutive agonist pulses (denoted as 'P1' and 'P2') was chosen in a series of preliminary experiments so that the amplitude of the second pulse was significantly (but not completely) reduced due to receptor desensitization (Khiroug et al., 2003) .
Then, the ratio of response amplitudes (the P2/P1 ratio) was a measure of the rate of recovery of desensitization. Since there was variability in this ratio from cell to cell, as well as changes in amplitudes (either increases or decreases) occasionally during the timecourse of experiments (e.g. we often observed rundown of both α7 and non-α7 nAChRs during recordings), we normalized the changes in the P2/P1 ratio (R norm ) during experimental treatments as compared to the control mean value for each cell using the following equation; R norm = ( ex P2/ ex P1) / ( contr P2/ contr P1) where ex P1 and ex P2 are experimental, and contr P1 and contr P2 are control peak amplitude values.
Statistical analyses were performed using Origin software (Microcal, Northampton, MA) .
Averaged data were presented as mean ± s.e.m., and statistical significance was tested using an ANOVA.
This article has not been copyedited and formatted. The final version may differ from this version. mRNA was transcribed in vitro from plasmids using the mMessage Machine kit (Ambion) according to conditions suggested by the manufacturer. The rat nAChR α7, α4, and β2 plasmids were kindly provided by J. Patrick. Female Xenopus laevis frogs were anaesthetized by immersion in cold water containing 0.2 % ethylmetaaminobenzoate (MS-222; Sigma) for 60 min, and decapitated. Oocytes were dissected and defolliculated by treatment with collagenase B (Boehringer Mannheim, 3-4 mg/ml) for 2-4 hr in a solution containing (in mM): 85.2 NaCl, 2
KCl, 1 MgCl 2 , and 5 HEPES. The total amount of RNA injected for each nAChR subunit was 25 ng. Experiments were performed 3 to 8 days after injection.
Current responses were obtained by two-electrode voltage-clamp recording at a holding potential of -60 mV (unless otherwise stated) using a Geneclamp 500 and pCLAMP 8 software (Axon Instruments) in a solution containing (in mM): 96 NaCl, 2 KCl, 1.8 CaCl 2 , 1 MgCl 2 , and 10 HEPES (pH 7.4). Oocytes were maintained in culture in the same solution, with the addition of 2.5 mM sodium pyruvate, 0.5 mM theophylline, 50 µg/ml gentamicin and 5% horse serum.
Typically traces were filtered at 0.2 to 1 kHz and sampled at 0.5 to 5 kHz. Electrodes contained
Results

Pharmacological properties of nAChR-mediated currents-activation of both α7 and non-α7 subtypes
In acute slices of rat hippocampus, the pressure application of ACh (2 mM) to voltageclamped CA1 stratum radiatum and stratum oriens interneurons elicited diverse nicotinic ACh receptor (nAChR)-mediated responses (Fig. 1) . To determine the molecular makeup of the receptors governing these responses, subunit-selective pharmacological agents were used. The α7-containing nAChRs are rapidly activated and desensitized, and are potently and selectively blocked by methyllycaconitine (MLA). In addition, choline has been reported to be a selective agonist of α7-containing nAChRs (Papke et al., 1996) . Most of the interneurons studied here (> 95%) express α7-containing nAChRs, which can be activated when using short duration (e.g. 100 msec) agonist pressure applications. Under these conditions, responses induced by maximal doses of ACh (2 mM) or choline (10 mM; Khiroug et al., 2002) are identical in peak amplitude and time course, and are completely blocked by MLA (10 nM; Fig. 1A ). In some α7-containing interneurons, ACh also appears to activate a slower non-α7 nAChR-mediated response. In these cells, choline only induces rapid responses that are completely blocked by MLA, whereas ACh responses peak rapidly and decay with a slower secondary component that is insensitive to block by MLA (Fig. 1B) ; this slower component is blocked by dihydro-β-erythroidine (DHβE; 10 µM), a competitive antagonist of non-α7 nAChRs (data not shown). In some rare interneurons (< 5%), only non-α7 nAChRs appear to be expressed since ACh, but not choline, induces slowThis article has not been copyedited and formatted. The final version may differ from this version.
activating responses that are unaffected by MLA (data not shown), but are blocked by DHβE (Fig. 1C) .
The diverse functional and pharmacological properties of nAChR-mediated responses in these interneurons is consistent with previous reports from various groups showing that these neurons express a diverse array of nAChRs, including α7-containing and a variety of non-α7
subtypes (Jones and Yakel, 1997; Alkondon et al. 1998; Frazier et al. 1998; McQuiston and Madison, 1999; Sudweeks and Yakel, 2000) . In addition, by combining differential sensitivity to specific agonists and antagonists, we are able to isolate and effectively study the α7-from the non-α7-containing nAChR populations in individual cells.
Regulation of α7-containing nAChRs by AChE inhibitors
In interneurons with predominantly α7-containing nAChR-mediated responses, the various inhibitors of acetylcholinesterase (AChE) that we have investigated (i.e. huperzine A, tacrine, and BW284c51) had no significant effect on either the amplitude or kinetics of α7 nAChR-mediated responses. However, these inhibitors appeared to have an effect on the rate of recovery from desensitization, which we studied using a dual-pulse protocol.
The α7-containing nAChRs in rat hippocampal CA1 stratum radiatum interneurons in slices desensitize with a biphasic time course (pressure application of 2 mM ACh), with time constants of 117 msec (68% of the fit) and 1.29 sec (Khiroug et al., 2003) . In addition, these α7-containing nAChRs recovered from desensitization (when activated by the local photolysis of caged carbachol) with a time course of ~ 20 sec (Khiroug et al., 2003) . This recovery time is due in part to the rate of diffusion of ACh away from the receptors, and is consistent with the time course of decay of the non-desensitizing non-α7 nAChRs, which had an average half-time of decay of ~ 4 sec (see below). To explore potential changes to the rate of recovery from desensitization due to AChE inhibitors, a second pulse of ACh (denoted as 'P2') was applied 10 sec after the first ('P1'; both for 100 msec durations; see Methods). The amplitude of the second ACh pulse (P2) was significantly reduced (relative to the first; P1) due to receptor desensitization, to a value of 84 + 2% (52 cells; Fig. 2A) ; this value will be defined as the P2/P1
ratio. All three AChE inhibitors were found to significantly and dose-dependently reduce this P2/P1 ratio for ACh-induced responses ( Fig. 2A) , most likely signifying that they decrease the rate of recovery from desensitization through an indirect mechanism since they would be expected to result in the persistence of ACh due to a reduction in breakdown, which would cause persistent desensitization of the receptors. This is consistent with the significant increase in the time course of decay of the non-α7 nAChRs to ~ 21 sec after treatment with BW284c51
(1 µM; see below). BW284c51 was the most potent of the three, and its effects were the most rapidly reversible (for 10 min washout; data not shown). The P2/P1 ratio was not affected by DHβE (1-10 µM; 12 cells), which indicates that non-α7 nAChRs were not involved in the alteration in this ratio.
With a fast-desensitizing channel such as the α7 nAChR, inhibiting the function of AChE would be expected to increase desensitization (e.g. to reduce the recovery from desensitization), which is consistent with our data. To further explore this possibility, we used choline (10 mM), a selective activator of α7-containing nAChRs and not a substrate for AChE.
Using the dual-pulse protocol mentioned above, the P2/P1 ratio for choline-induced responses was 65 + 4% (25 cells; Fig. 2B ), which is significantly less than for ACh; this apparent slower recovery from desensitization of choline-induced responses is likely due to the persistence of This article has not been copyedited and formatted. The final version may differ from this version.
choline (since it is not broken down by AChE), which causes the persistent desensitization of the receptors. In contrast to ACh, the P2/P1 ratio for choline-induced responses was not significantly affected by exposure to any of the three AChE inhibitors (Fig. 2B ). This data is consistent with the fact that these AChE inhibitors are not having a direct effect on the nAChRs themselves, or else choline-induced responses should have been affected. Furthermore, this data suggests that these AChE inhibitors exert their effect selectively on ACh-induced responses because their actions result in an increase in the concentration of ACh (due to a reduction in breakdown), and that this increase in ACh is altering the P2/P1 ratio for ACh-induced responses by decreasing the rate of recovery from desensitization.
Carbachol is another agonist, similar to ACh, that will activate both α7-containing and non-α7 nAChRs, as well as muscarinic ACh receptors. However unlike ACh, carbachol (like choline) is not a substrate for AChE. Therefore, we tested whether the effects of carbachol might be sensitive to these AChE inhibitors. Brief pressure applications of carbachol (4 mM)
induced α7 nAChR-mediated responses with similar amplitudes and kinetics as ACh and choline ( Fig. 2C ). Using the dual-pulse protocol, the P2/P1 ratio for carbachol was 48 + 5% (20 cells; Fig. 2C ), which is significantly less than for either ACh or choline; this apparent slower recovery from desensitization of carbachol-induced responses is likely due to the persistence of carbachol (since it is not broken down by AChE), which causes the persistent desensitization of the receptors. This is consistent with the slow time course of decay of non-α7 nAChRs activated by carbachol (see below). In addition, this ratio was unaltered by exposure to any of the three AChE inhibitors studied ( Fig. 2C ), similar to responses activated by choline, but in contrast to those activated by ACh. As with ACh, this P2/P1 ratio for carbachol-induced responses was not affected by DHβE (1-10 µM; 9 cells).
This article has not been copyedited and formatted. The final version may differ from this version. Since neither choline nor carbachol are substrates for AChE, the inhibition of AChE would not be expected to alter choline-or carbachol-induced responses unless these inhibitors are having direct effects on the nAChRs themselves. This was not the case since neither the kinetics, amplitudes, nor recovery from desensitization of α7-containing nAChR responses activated by either choline or carbachol were affected by huperzine A, tacrine, and BW284c51.
However, since these AChE inhibitors did have an effect on the recovery of desensitization of ACh-induced responses only, this suggests that the effects of these inhibitors on the function of the α7-containing nAChRs is indirect (i.e. by inhibiting the function of AChE and increasing
ACh levels).
Preincubation with DFP, an irreversible AChE inhibitor, mimics the effects of reversible AChE inhibitors
Diisopropylflurophosphate (DFP) is an organophosphate that covalently modifies and irreversibly inhibits AChE function, and can induce long-term cognitive deficits and alterations in expression of cholinergic receptors (Upchurch and Wehner, 1987; Bushnell et al., 1991; Prendergast et al., 1997; Stone et al., 2000) . Slices were preincubated with high (100 µM)
doses of DFP for 30 min, then washed for > 1 hour. In these DFP preincubated slices (e.g.
without any AChE inhibitors), ACh and choline still activated α7-containing nAChR responses in interneurons (Fig. 3A) , however the P2/P1 ratio for ACh responses was significantly reduced to 33 + 3% (3 cells) as compared to the control value of 84% (see above), while the P2/P1 ratio for choline responses was not significantly changed (74 + 4% in 3 cells preincubated with DFP as compared to 65% for controls; Fig. 3B ). Furthermore, the addition of BW284c51 to these preincubated slices had no further effect on the P2/P1 ratio for ACh-induced responses (Fig. 3 ).
This article has not been copyedited and formatted. The final version may differ from this version. Therefore preincubation with DFP appeared to mimic the effect of bath application of the determined (at least in part) by the breakdown of ACh by AChE. Similar effects on amplitude and decay rate were also observed with both huperzine A and tacrine (data not shown). In slices preincubated with DFP, the decay of ACh responses was much slower (24 + 2 sec; 4 cells) than controls (Fig. 4C) . In fact, the time course of decay of ACh responses in DFP treated slices was not significantly different from the time courses with BW284c51 (for ACh), and for carbachol responses (Fig. 4D) . Therefore, as with the data from α7-containing nAChRs, preincubation with DFP appeared to mimic the effect of bath application of the reversible AChE inhibitors.
Furthermore, this data also suggests that these AChE inhibitors are not having a direct potentiating effect on the non-α7 nAChR itself, since carbachol responses were unaffected.
Regulation of α7 and non-α7 nAChRs by galantamine
Galantamine is another inhibitor of AChE that has previously been reported to be an allosteric potentiator of nAChRs (Maelicke et al., 2000; Samochocki et al., 2003) . We compared the effect of galantamine on both the α7 and non-α7 nAChRs to the other AChE inhibitors that we tested. Similar to the effects of all three AChE inhibitors, the amplitude and kinetics of α7-containing nAChR responses were not significantly affected by galantamine (up to 10 µM), and the P2/P1 ratio for ACh responses was significantly and dose-dependently reduced (although higher doses of galantamine were required to produce the same effect; Fig.   5A ,B). In addition, similar to the effect of the other AChE inhibitors, the P2/P1 ratio for choline responses was not significantly affected by galantamine (Fig. 5A,B ).
In cells with functional non-α7 nAChRs, galantamine also had similar effects to the other AChE inhibitors. The bath application of galantamine (10 µM) potentiated the response to ACh by 87 + 24% (5 cells; Fig. 5C ), and significantly slowed the half-time of decay from 2.8 + This article has not been copyedited and formatted. The final version may differ from this version. 0.3 sec to 11 + 1 sec; lower doses of galantamine were less effective. Furthermore, the activation of these non-α7 nAChRs by carbachol was unaffected by galantamine (data not shown). This data suggests that under the current experimental conditions, galantamine, like the other AChE inhibitors that we have tested, is affecting nAChR function through an indirect mechanism of action.
Effect of AChE inhibitors on rat α7 and α4β2 nAChR channels expressed in Xenopus oocytes
To further test whether AChE inhibitors may have direct effects on nAChR function, we expressed rat α7 and α4β2 nAChR channels in Xenopus oocytes since it has been suggested that these are the major subtypes of nAChRs in rat hippocampal interneurons (Alkondon and Albuquerque, 1993; Frazier et al., 1998; McQuiston and Madison, 1999) . As previously shown (Khiroug et al., 2002) , the rapid application of ACh (2 mM) to oocytes expressing the rat α7
nAChR subunit induced inward current responses (at a holding potential of -60 mV) that activated and decayed rapidly (Fig. 6A) . When using the dual-pulse protocol as mentioned above (however slightly modified by applying ACh for 500 msec duration at 6 sec intervals), neither the amplitude nor kinetics of the responses, nor the P2/P1 ratio, were significantly altered by either BW284c51 (100 nM or 1 µM; 3 cells), tacrine (1 µM; 3 cells), or huperzine A
(1 µM; 3 cells) (Fig. 6A ). These data suggest that these AChE inhibitors are not having a direct effect on α7 nAChR function expressed in Xenopus oocytes at the concentrations used in this study.
The application of ACh (1 mM for 3 sec) to oocytes expressing the rat α4β2 nAChR channels induces responses that activate and decay much more slowly than α7 nAChRs (Fig.   6B ). Furthermore, the bath application of BW284c51 (100 nM; 3 cells) had no significant effect This article has not been copyedited and formatted. The final version may differ from this version. and BW284c51 (huperzine A and tacrine are known cognitive enhancers, and tacrine is presently used to treat AD), do not directly affect the amplitude or kinetics of these receptors.
The lack of direct effect was also observed in Xenopus oocytes expressing rat α7 and α4β2 nAChR channels, which have been suggested to be the major subtypes of nAChRs in rat hippocampal interneurons. Instead, these inhibitors slowed the rate of recovery from desensitization of the α7-containing nAChRs in rat hippocampal interneurons through an indirect mechanism (i.e. since they cause the persistence of ACh due to a reduction in breakdown, which causes persistent desensitization of the receptors), and increased both the amplitude and decay time of the non-α7 nAChR-mediated responses, through an indirect mechanism involving the inhibition of the breakdown of ACh, resulting in an enhanced amount or duration of ACh exposed to these channels.
AChE is encoded by a single gene, however it exists in a variety of functional forms (which share similar catalytic properties) due to alternative mRNA splicing and association with This article has not been copyedited and formatted. The final version may differ from this version. this secreted soluble form is thought to hydrolyze ACh in the extracellular space more effectively than the membrane-bound form. In contrast to the neuromuscular junction, no foci of AChE exists at synaptic zones; instead it is found along pre-and postsynaptic membranes. . These groups also found that tacrine was not an allosteric potentiator of nAChRs, which is consistent with our data. Therefore the beneficial effects of tacrine and huperzine A (which we also found was not an allosteric potentiator of nAChRs in our system) on cognition (and perhaps in the treatment of AD) is most likely not due to a direct allosteric potentiation of nAChRs, but instead is probably due to the direct regulation of ACh concentration by AChE.
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Under the experimental conditions used here (i.e. maximal doses of agonists), we found that galantamine produced the same effects on both the α7 and non-α7 nAChRs, effects that were indirect and therefore not likely to be due to direct binding to and regulation of channel function. The fact that we did not appear to observe an allosteric potentiating effect of galantamine was also consistent with Samochocki et al. (2003), who observed potentiation of nAChR function only with submaximal doses of agonist. Lastly, the dose-dependency of the effect of galantamine that we observed was also more consistent with the inhibition of AChE since concentrations of galantamine > 1 µM were required for maximal regulation of nAChR function (consistent with the ability of galantamine to inhibit AChE, with an IC 50 value of ~ 3 mM), whereas maximal allosteric potentiation was observed at concentrations of galantamine of et al., 2003) .
The potentiation of non-α7 nAChRs by AChE inhibition is consistent with the wellknown link of nAChRs, in particular non-α7 nAChRs, to cognition and AD (Picciotto et al., 1995; Levin, 2002) . The non-α7 nAChRs have been shown to pattern network activity in rodent hippocampus via the regulation of theta activity (Cobb et al., 1999) , and there is a substantial decrease in the number of nAChRs (in particular α4-containing) in AD patients (Paterson and Nordberg, 2000; Court et al., 2001) . However, it is not clear at the moment how the regulation that we have observed with the α7-containing nAChRs (i.e. the prolongation of the recovery from desensitization) by AChE inhibition is related to cognition and/or AD, since block of α7-containing nAChRs in the hippocampus appears to impair memory performance (Levin, 2002) .
Altering ACh levels by blocking its hydrolysis would be expected to affect not only nAChRs, but also muscarinic ACh receptors as well, whose function has also been linked to cognition and Although the rate of ACh hydrolysis by AChE is extremely fast, Descarries et al. (1997) have suggested that in the brain (as opposed to the neuromuscular junction), the rapid elimination of ACh occurs mainly through diffusion and not hydrolysis by AChE. Therefore, they have suggested that the inhibition of AChE will only have minimal effects on cholinergic synaptic transmission. However we have shown that endogenous AChE is extremely effective and rapid in hydrolyzing exogenously-applied ACh since the decay of the non-α7 nAChRmediated responses was dramatically slowed by AChE inhibition; the half-time of decay of ACh-induced responses was increased to ~ 21 sec after AChE inhibition as opposed to ~ 4 sec before. The fact that ACh responses decayed in 4 sec (when the activity of AChE was not This article has not been copyedited and formatted. The final version may differ from this version.
inhibited) demonstrates how fast the hydrolysis of ACh is occurring in these slices. In the future it will be important to investigate how synaptically activated nAChR-mediated responses (i.e.
due to activation by endogenous ACh) are modified by AChE activity.
Previous reports have shown that α7-containing nAChRs are located at postsynaptic sites on hippocampal interneurons and mediate fast cholinergic excitatory synaptic transmission (Frazier et al., 1998; Alkondon et al., 1998) . In addition, it was recently shown that these α7-containing nAChRs were located primarily at perisomatic sites (<70 µm from the soma; Khiroug et al. , 2003) . Whether these receptors might also be located and function extrasynaptically remains to be determined. Furthermore, it is not known at the moment whether the non-α7
nAChRs, which because of their slow activation and desensitization might be more suited to an extrasynaptic role, are located at postsynaptic sites and can mediate fast cholinergic excitatory synaptic transmission in the hippocampus. There is evidence in the hippocampus that most of the cholinergic action may be mediated by nonsynaptic, diffuse, so called 'volume transmission'
(Descarries et al., 1997). The α7-containing nAChRs have also been found on presynaptic terminals in the hippocampus, where their activation increased intraterminal Ca 2+ levels and facilitated transmitter release (Gray et al., 1996) , however others have failed to observe this effect (Vogt and Regehr, 2001) . How these various subtypes of nAChRs are normally activated and regulated by endogenous ACh, and how AChE activity may regulate this, remains to be determined. Despite these questions that remain to explain the multifaceted cholinergic signaling mechanisms, we have shown significant effects of AChE action in hippocampal slices, and thus this enzyme is likely to have a significant impact on cholinergic receptor-mediated synaptic and extrasynaptic signaling pathways. Understanding these various pathways, that are important to hippocampal activity since dysfunctions in these pathways are known to occur in This article has not been copyedited and formatted. The final version may differ from this version.
AD (and other neurological disorders), will shed light that will aid in the further development of drugs for the treatment of AD.
This article has not been copyedited and formatted. The final version may differ from this version. A. In a Xenopus oocyte expressing α7 nAChRs, a dual-pulse protocol was used to activate these channels whereby a second pulse of ACh (2 mM) was applied 6 sec after the first (500 msec duration for both). The application of BW284c51 ('BW'; 100 nM) had no significant effect on either the amplitude or kinetics of either the first or second response to ACh. B. In a Xenopus oocyte expressing α4β2 nAChRs that were activated by ACh (1 mM; 3 sec), BW284c51 ('BW'; 100 nM) had no significant effect on the amplitude or decay of current responses.
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